Global In Vitro Diagnostics (IVD) Market Global Industry Insights, and Opportunity Analysis - 2024
In Vitro Diagnostics (IVD) Market report categorizes global market by Product Type (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Disorders), End User (Hospitals, Laboratories, Homecare Diagnostics, Research Institutes), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024
In Vitro Diagnostics (IVD) Market report categorizes global market by Product Type (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Disorders), End User (Hospitals, Laboratories, Homecare Diagnostics, Research Institutes), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
REPORT DESCRIPTION<br />
<strong>In</strong>fectious diseases has emerged as the highest revenue contributor<br />
among application segment<br />
<strong>In</strong>fectious diseases has emerged as the highest revenue generating application for <strong>In</strong> vitro<br />
diagnostics (<strong>IVD</strong>) market industry players. The segment is expected to grow by 1.5X at a CAGR<br />
of 4.4% between 2016 <strong>and</strong> <strong>2024</strong>. <strong>In</strong>fectious diseases prevalence has increased considerably in<br />
past. Morbidity cases in tuberculosis, salmonella <strong>and</strong> meningococcal disease was as high as<br />
90,000 in U.S. in 2016. As a result, the dem<strong>and</strong> for <strong>IVD</strong> from diagnostic centers has increased<br />
substantially. As per the Centers for Disease Control <strong>and</strong> Prevention (CDC), over 3.9 million<br />
patients visited hospital outpatient department for infectious <strong>and</strong> parasitic diseases. Dem<strong>and</strong><br />
for <strong>IVD</strong> is expected to register fastest growth in detection of autoimmune disorders <strong>and</strong><br />
infectious diseases.North America is highest contributing region for <strong>In</strong> vitro diagnostics (<strong>IVD</strong>)<br />
market, with a projected market share of 46.7% by <strong>2024</strong>, exp<strong>and</strong>ing at the fastest CAGR of<br />
5.4% between 2016 <strong>and</strong> <strong>2024</strong>. Changing healthcare l<strong>and</strong>scape, favorable regulatory policies<br />
such as Medicaid <strong>and</strong> Medicare along with significant healthcare spending (16.7%) is expected<br />
to boost the market for <strong>IVD</strong> in the region.<br />
Request report sample for more professional <strong>and</strong> technical insights:<br />
https://www.coherentmarketinsights.com/insight/request-sample/195<br />
© Coherent market <strong>In</strong>sights. All Rights Reserved
Change language